Related Experiment Video
Updated: Feb 27, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
Small-molecule stabilization of the p53 - 14-3-3 protein-protein interaction
Richard G Doveston1, Ave Kuusk1,2, Sebastian A Andrei1
1Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology, The Netherlands.
Abstract:
14-3-3 proteins are positive regulators of the tumor suppressor p53, the mutation of which is implicated in many human cancers. Current strategies for targeting of p53 involve restoration of wild-type function or inhibition of the interaction with MDM2, its key negative regulator. Despite the efficacy of these strategies, the alternate approach of stabilizing the interaction of p53 with positive regulators and, thus, enhancing tumor suppressor activity, has not been explored. Here, we report the first example of small-molecule stabilization of the 14-3-3 - p53 protein-protein interaction (PPI) and demonstrate the potential of this approach as a therapeutic modality. We also observed a disconnect between biophysical and crystallographic data in the presence of a stabilizing molecule, which is unusual in 14-3-3 PPIs.
Insights
Researchers discovered small molecules that stabilize the 14-3-3 protein interaction with tumor suppressor p53, offering a new therapeutic strategy for cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- 14-3-3 proteins positively regulate the tumor suppressor p53, crucial for preventing human cancers.
- Mutations in p53 are common in many human cancers, highlighting its importance in tumor suppression.
- Current cancer therapies targeting p53 focus on restoring its function or inhibiting its negative regulator, MDM2.
Discussion:
- This study explores a novel therapeutic strategy: enhancing p53's tumor suppressor activity by stabilizing its interaction with positive regulators like 14-3-3 proteins.
- The research presents the first instance of small-molecule stabilization of the 14-3-3 - p53 protein-protein interaction (PPI).
- This approach offers a new avenue for cancer treatment by boosting the natural tumor-suppressing capabilities of p53.
Key Insights:
- Demonstrated the potential of small-molecule-mediated stabilization of the 14-3-3 - p53 PPI as a therapeutic modality.
- Identified a novel approach to cancer therapy by enhancing tumor suppressor activity.
- Observed an unusual discrepancy between biophysical and crystallographic data when using the stabilizing molecule in 14-3-3 PPIs.
Outlook:
- This work opens new possibilities for developing targeted cancer therapies.
- Further research into the mechanism of small-molecule stabilization could lead to more effective drugs.
- Investigating the observed data disconnect may reveal new insights into protein-protein interactions.
Related Concept Videos
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Drugs that Stabilize Microtubules

